Showing results (981-990 of 1,861) with videos related to

Sort By:
Pageof 187
Clinical Pharmacology and Therapeutics|May 26, 2025
Absolute Oral Bioavailability and Bioequivalence of LSD Base and Tartrate in a Double-Blind, Placebo-Controlled, Crossover StudyDenis Arikci, Friederike Holze, Lorenz Mueller, et al.
Molecular Cancer|March 5, 2013
Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancerRebekah L Zinn, Eric E Gardner, Irina Dobromilskaya, et al.
Neuroimage|October 18, 2020
Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in miceJoanes Grandjean, David Buehlmann, Michaela Buerge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103Charles M Rudin, Ravi Salgia, Xiaofei Wang, et al.
Heroin Addiction and Related Clinical Problems|May 18, 2026
An uncontrolled pilot trial of a buprenorphine dispensing device to enhance outpatient treatment for opioid use disorderKevin Wenzel, Julia Thomas, Michael S Davis, et al.
European Journal of Immunology|March 5, 2003
CD4 T cell activation by myelin oligodendrocyte glycoprotein is suppressed by adult but not cord blood CD25+ T cellsKajsa Wing, Susanne Lindgren, Gittan Kollberg, et al.
Oncogene|February 6, 2003
Bcl-x(L) and Akt cooperate to promote leukemogenesis in vivoRobyn Karnauskas, Qun Niu, Sunit Talapatra, et al.
Journal of Digital Imaging|February 24, 2007
An algorithm for tracking microcatheters in fluoroscopyAkihiro Takemura, Kenneth R Hoffmann, Masayuki Suzuki, et al.
Arthritis Research & Therapy|July 22, 2018
Sex-based differences in association between circulating T cell subsets and disease activity in untreated early rheumatoid arthritis patientsJonathan Aldridge, Jayesh M Pandya, Linda Meurs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon-alpha2b in patients with multiple myeloma maintained on a steady dose of interferon-alpha2bB Sirohi, R Powles, D Lawrence, et al.
Pageof 187